ghk cu peptide injection dosage 100mg GHK-Cu Chart: 100 mg Vial Protocol ghk cu daily dose Ghk-cu

At the 12-month follow-up : 87.5% of patients reported significant relief defined as 50% reduction in baseline pain scores Mean VAS pain score dropped from 7.2 at baseline to 2.8 at 12 months KOOS (Knee Injury and Osteoarthritis Outcome Score) improved across all subscales: pain, symptoms, activities of daily living, sport/recreation, and quality of life No serious adverse events were reported across the treatment period The durability of the response at 12 months is particularly notable

Available research indicates it operates through enzymatic modulation rather than hormonal pathways

doi:10.1080/17474124.2023.2204229

It also influences epigenetic methylation patterns in animal aging models

A.WrightP